United States (US) Psoriasis Drugs Market (2025-2031) | Companies, Growth, Outlook, Value, Industry, Share, Trends, Analysis, Segmentation, Size & Revenue, Forecast, Competitive Landscape

Market Forecast By Therapeutic Class (Tumor Necrosis Factor Inhibitor, Interleukin Inhibitors), By Treatment (Topicals, Systemic, Biologics) And Competitive Landscape
Product Code: ETC9974733 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Psoriasis Drugs Market Outlook
  • Market Size of United States (US) Psoriasis Drugs Market, 2024
  • Forecast of United States (US) Psoriasis Drugs Market, 2031
  • Historical Data and Forecast of United States (US) Psoriasis Drugs Revenues & Volume for the Period 2021- 2031
  • United States (US) Psoriasis Drugs Market Trend Evolution
  • United States (US) Psoriasis Drugs Market Drivers and Challenges
  • United States (US) Psoriasis Drugs Price Trends
  • United States (US) Psoriasis Drugs Porter's Five Forces
  • United States (US) Psoriasis Drugs Industry Life Cycle
  • Historical Data and Forecast of United States (US) Psoriasis Drugs Market Revenues & Volume By Therapeutic Class for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Psoriasis Drugs Market Revenues & Volume By Tumor Necrosis Factor Inhibitor for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Psoriasis Drugs Market Revenues & Volume By Interleukin Inhibitors for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Psoriasis Drugs Market Revenues & Volume By Treatment for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Psoriasis Drugs Market Revenues & Volume By Topicals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Psoriasis Drugs Market Revenues & Volume By Systemic for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Psoriasis Drugs Market Revenues & Volume By Biologics for the Period 2021- 2031
  • United States (US) Psoriasis Drugs Import Export Trade Statistics
  • Market Opportunity Assessment By Therapeutic Class
  • Market Opportunity Assessment By Treatment
  • United States (US) Psoriasis Drugs Top Companies Market Share
  • United States (US) Psoriasis Drugs Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Psoriasis Drugs Company Profiles
  • United States (US) Psoriasis Drugs Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Psoriasis Drugs Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Psoriasis Drugs Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Psoriasis Drugs Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Psoriasis Drugs Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Psoriasis Drugs Market - Industry Life Cycle

3.4 United States (US) Psoriasis Drugs Market - Porter's Five Forces

3.5 United States (US) Psoriasis Drugs Market Revenues & Volume Share, By Therapeutic Class, 2021 & 2031F

3.6 United States (US) Psoriasis Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F

4 United States (US) Psoriasis Drugs Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of psoriasis in the US population

4.2.2 Growing awareness about psoriasis and its treatment options

4.2.3 Technological advancements in drug development for psoriasis

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval

4.3.2 High cost associated with psoriasis drugs

4.3.3 Presence of alternative treatment options such as biologics and phototherapy

5 United States (US) Psoriasis Drugs Market Trends

6 United States (US) Psoriasis Drugs Market, By Types

6.1 United States (US) Psoriasis Drugs Market, By Therapeutic Class

6.1.1 Overview and Analysis

6.1.2 United States (US) Psoriasis Drugs Market Revenues & Volume, By Therapeutic Class, 2021- 2031F

6.1.3 United States (US) Psoriasis Drugs Market Revenues & Volume, By Tumor Necrosis Factor Inhibitor, 2021- 2031F

6.1.4 United States (US) Psoriasis Drugs Market Revenues & Volume, By Interleukin Inhibitors, 2021- 2031F

6.2 United States (US) Psoriasis Drugs Market, By Treatment

6.2.1 Overview and Analysis

6.2.2 United States (US) Psoriasis Drugs Market Revenues & Volume, By Topicals, 2021- 2031F

6.2.3 United States (US) Psoriasis Drugs Market Revenues & Volume, By Systemic, 2021- 2031F

6.2.4 United States (US) Psoriasis Drugs Market Revenues & Volume, By Biologics, 2021- 2031F

7 United States (US) Psoriasis Drugs Market Import-Export Trade Statistics

7.1 United States (US) Psoriasis Drugs Market Export to Major Countries

7.2 United States (US) Psoriasis Drugs Market Imports from Major Countries

8 United States (US) Psoriasis Drugs Market Key Performance Indicators

8.1 Patient adherence rate to prescribed psoriasis drugs

8.2 Number of clinical trials for new psoriasis treatments

8.3 Rate of adoption of novel drug delivery technologies in psoriasis treatment

8.4 Average time to market for new psoriasis drugs

8.5 Patient-reported outcomes and satisfaction with psoriasis drug therapies

9 United States (US) Psoriasis Drugs Market - Opportunity Assessment

9.1 United States (US) Psoriasis Drugs Market Opportunity Assessment, By Therapeutic Class, 2021 & 2031F

9.2 United States (US) Psoriasis Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F

10 United States (US) Psoriasis Drugs Market - Competitive Landscape

10.1 United States (US) Psoriasis Drugs Market Revenue Share, By Companies, 2024

10.2 United States (US) Psoriasis Drugs Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All